Best AI Index Fund to Buy
Over the last two years, companies with a focus on…
Buy
69
CURI Quote, Financials, Valuation and Earnings
Last price:
$6.82
Seasonality move
:
4.03%
Day range:
$6.35 - $6.88
52-week range:
$0.98 - $6.98
Dividend yield:
1.69%
P/E ratio:
--
P/S ratio:
6.97x
P/B ratio:
6.74x
Volume:
567.2K
Avg. volume:
870.7K
1-year change:
555.77%
Market cap:
$391.5M
Revenue:
$51.1M
EPS (TTM):
-$0.14
| Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
|---|---|---|---|---|---|---|
| Revenue | $39.6M | $71.3M | $78M | $56.9M | $51.1M | |
| Revenue Growth (YoY) | 119.8% | 79.86% | 9.52% | -27.11% | -10.12% | |
| Cost of Revenues | $15.4M | $36.7M | $51.5M | $35.6M | $25.4M | |
| Gross Profit | $24.2M | $34.6M | $26.5M | $21.3M | $25.8M | |
| Gross Profit Margin | 61.09% | 48.54% | 33.97% | 37.51% | 50.4% | |
| R&D Expenses | -- | -- | -- | -- | -- | |
| Selling, General & Admin | $63M | $87.1M | $78.2M | $46.8M | $39.1M | |
| Other Inc / (Exp) | -$10.1M | $14.7M | $955K | -$24.2M | -$2.6M | |
| Operating Expenses | $63M | $87.1M | $78.2M | $46.8M | $39.1M | |
| Operating Income | -$38.8M | -$52.5M | -$51.7M | -$25.5M | -$13.3M | |
| Net Interest Expenses | -- | -- | -- | -- | -- | |
| EBT. Incl. Unusual Items | -$48.4M | -$37.3M | -$50.6M | -$48.4M | -$12.8M | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | $179K | $360K | $367K | $506K | $132K | |
| Net Income to Company | -$48.6M | -$37.6M | -$50.9M | -$48.9M | -$12.9M | |
| Minority Interest in Earnings | -- | -- | -- | -- | -- | |
| Net Income to Common Excl Extra Items | -$48.6M | -$37.6M | -$50.9M | -$48.9M | -$12.9M | |
| Basic EPS (Cont. Ops) | -$3.30 | -$0.73 | -$0.96 | -$0.92 | -$0.24 | |
| Diluted EPS (Cont. Ops) | -$3.30 | -$1.02 | -$0.96 | -$0.92 | -$0.24 | |
| Weighted Average Basic Share | $18.9M | $51.5M | $52.8M | $53M | $54.5M | |
| Weighted Average Diluted Share | $18.9M | $51.8M | $52.8M | $53M | $54.5M | |
| EBITDA | -$28.7M | -$24M | -$11.7M | -$2.1M | $6.1M | |
| EBIT | -$38.8M | -$52.5M | -$51.7M | -$25.5M | -$13.3M | |
| Revenue (Reported) | $39.6M | $71.3M | $78M | $56.9M | $51.1M | |
| Operating Income (Reported) | -$38.8M | -$52.5M | -$51.7M | -$25.5M | -$13.3M | |
| Operating Income (Adjusted) | -$38.8M | -$52.5M | -$51.7M | -$25.5M | -$13.3M | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Revenue | $9.9M | $17.6M | $12.4M | $12M | $15.1M | |
| Revenue Growth (YoY) | 33.07% | 77.41% | -29.73% | -3.12% | 25.74% | |
| Cost of Revenues | $4.2M | $11.9M | $9M | $6.7M | $7.1M | |
| Gross Profit | $5.8M | $5.8M | $3.4M | $5.3M | $8M | |
| Gross Profit Margin | 58.15% | 32.77% | 27.34% | 43.77% | 53.08% | |
| R&D Expenses | -- | -- | -- | -- | -- | |
| Selling, General & Admin | $21M | $25.3M | $11.2M | $8.9M | $7.9M | |
| Other Inc / (Exp) | -$3.8M | $3.7M | -$293K | -$1.8M | -$158K | |
| Operating Expenses | $21M | $25.3M | $11.2M | $8.9M | $7.9M | |
| Operating Income | -$15.2M | -$19.5M | -$7.8M | -$3.7M | $79K | |
| Net Interest Expenses | -- | $57K | -- | -- | -- | |
| EBT. Incl. Unusual Items | -$18.7M | -$15.8M | -$7.7M | -$5M | $347K | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | $26K | $45K | $58K | $34K | $28K | |
| Net Income to Company | -$18.8M | -$15.9M | -$7.8M | -$5M | $319K | |
| Minority Interest in Earnings | -- | -- | -- | -- | -- | |
| Net Income to Common Excl Extra Items | -$18.8M | -$15.9M | -$7.8M | -$5M | $319K | |
| Basic EPS (Cont. Ops) | -$0.39 | -$0.30 | -$0.15 | -$0.09 | $0.01 | |
| Diluted EPS (Cont. Ops) | -$0.39 | -$0.30 | -$0.15 | -$0.09 | $0.01 | |
| Weighted Average Basic Share | $48.1M | $52.8M | $53M | $53.3M | $57.1M | |
| Weighted Average Diluted Share | $48.1M | $52.8M | $53M | $53.3M | $57.1M | |
| EBITDA | -$12.4M | -$10.2M | -$1.8M | $1.7M | $3.6M | |
| EBIT | -$15.2M | -$19.5M | -$7.8M | -$3.7M | $79K | |
| Revenue (Reported) | $9.9M | $17.6M | $12.4M | $12M | $15.1M | |
| Operating Income (Reported) | -$15.2M | -$19.5M | -$7.8M | -$3.7M | $79K | |
| Operating Income (Adjusted) | -$15.2M | -$19.5M | -$7.8M | -$3.7M | $79K | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Revenue | $42.1M | $79M | $72.8M | $56.5M | $54.2M | |
| Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
| Cost of Revenues | $16.9M | $44.4M | $48.7M | $33.3M | $25.7M | |
| Gross Profit | $25.2M | $34.6M | $24.1M | $23.2M | $28.5M | |
| Gross Profit Margin | -- | -- | -- | -- | -- | |
| R&D Expenses | -- | -- | -- | -- | -- | |
| Selling, General & Admin | $67.1M | $91.4M | $64.1M | $44.6M | $38.1M | |
| Other Inc / (Exp) | -$3.8M | $22.2M | -$3M | -$25.7M | -$922K | |
| Operating Expenses | $67.1M | $91.4M | $64.1M | $44.6M | $38.1M | |
| Operating Income | -$41.9M | -$56.8M | -$40M | -$21.4M | -$9.6M | |
| Net Interest Expenses | -- | -- | -- | -- | -- | |
| EBT. Incl. Unusual Items | -$55.4M | -$34.4M | -$42.4M | -$45.7M | -$7.5M | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | $168K | $379K | $380K | $482K | $126K | |
| Net Income to Company | -$55.6M | -$34.8M | -$42.8M | -$46.2M | -$7.6M | |
| Minority Interest in Earnings | -- | -- | -- | -- | -- | |
| Net Income to Common Excl Extra Items | -$55.6M | -$34.8M | -$42.8M | -$46.2M | -$7.6M | |
| Basic EPS (Cont. Ops) | -$2.57 | -$0.66 | -$0.82 | -$0.87 | -$0.14 | |
| Diluted EPS (Cont. Ops) | -$2.57 | -$0.85 | -$0.82 | -$0.87 | -$0.14 | |
| Weighted Average Basic Share | ||||||
| Weighted Average Diluted Share | ||||||
| EBITDA | -$30.6M | -$21.9M | -$3.3M | $1.4M | $8.1M | |
| EBIT | -$41.9M | -$56.8M | -$40M | -$21.4M | -$9.6M | |
| Revenue (Reported) | $42.1M | $79M | $72.8M | $56.5M | $54.2M | |
| Operating Income (Reported) | -$41.9M | -$56.8M | -$40M | -$21.4M | -$9.6M | |
| Operating Income (Adjusted) | -$41.9M | -$56.8M | -$40M | -$21.4M | -$9.6M | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Revenue | $9.9M | $17.6M | $12.4M | $12M | $15.1M | |
| Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
| Cost of Revenues | $4.2M | $11.9M | $9M | $6.7M | $7.1M | |
| Gross Profit | $5.8M | $5.8M | $3.4M | $5.3M | $8M | |
| Gross Profit Margin | -- | -- | -- | -- | -- | |
| R&D Expenses | -- | -- | -- | -- | -- | |
| Selling, General & Admin | $21M | $25.3M | $11.2M | $8.9M | $7.9M | |
| Other Inc / (Exp) | -$3.8M | $3.7M | -$293K | -$1.8M | -$158K | |
| Operating Expenses | $21M | $25.3M | $11.2M | $8.9M | $7.9M | |
| Operating Income | -$15.2M | -$19.5M | -$7.8M | -$3.7M | $79K | |
| Net Interest Expenses | -- | $57K | -- | -- | -- | |
| EBT. Incl. Unusual Items | -$18.7M | -$15.8M | -$7.7M | -$5M | $347K | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | $26K | $45K | $58K | $34K | $28K | |
| Net Income to Company | -$18.8M | -$15.9M | -$7.8M | -$5M | $319K | |
| Minority Interest in Earnings | -- | -- | -- | -- | -- | |
| Net Income to Common Excl Extra Items | -$18.8M | -$15.9M | -$7.8M | -$5M | $319K | |
| Basic EPS (Cont. Ops) | -$0.39 | -$0.30 | -$0.15 | -$0.09 | $0.01 | |
| Diluted EPS (Cont. Ops) | -$0.39 | -$0.30 | -$0.15 | -$0.09 | $0.01 | |
| Weighted Average Basic Share | $48.1M | $52.8M | $53M | $53.3M | $57.1M | |
| Weighted Average Diluted Share | $48.1M | $52.8M | $53M | $53.3M | $57.1M | |
| EBITDA | -$12.4M | -$10.2M | -$1.8M | $1.7M | $3.6M | |
| EBIT | -$15.2M | -$19.5M | -$7.8M | -$3.7M | $79K | |
| Revenue (Reported) | $9.9M | $17.6M | $12.4M | $12M | $15.1M | |
| Operating Income (Reported) | -$15.2M | -$19.5M | -$7.8M | -$3.7M | $79K | |
| Operating Income (Adjusted) | -$15.2M | -$19.5M | -$7.8M | -$3.7M | $79K | |
| Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
|---|---|---|---|---|---|---|
| Cash and Equivalents | $11.2M | $15.2M | $40M | $37.7M | $7.8M | |
| Short Term Investments | $22.2M | $65.8M | $15M | -- | $24.2M | |
| Accounts Receivable, Net | $7.2M | $23.5M | $10.9M | $4.8M | $6.1M | |
| Inventory | -- | -- | -- | -- | -- | |
| Prepaid Expenses | -- | -- | -- | -- | -- | |
| Other Current Assets | $4.5M | $6.4M | $3.1M | $2.3M | $1.2M | |
| Total Current Assets | $51.2M | $113.3M | $69.5M | $45.3M | $39.5M | |
| Property Plant And Equipment | $1.3M | $1.2M | $4.8M | $4.1M | $3.6M | |
| Long-Term Investments | $2.8M | $25.4M | $10.8M | $6.4M | $11.3M | |
| Goodwill | -- | $2.8M | -- | -- | -- | |
| Other Intangibles | $32.9M | $74.2M | $68.5M | $44.9M | $31.5M | |
| Other Long-Term Assets | $254K | $689K | $539K | $358K | $257K | |
| Total Assets | $88.6M | $217.6M | $154.1M | $101M | $86.2M | |
| Accounts Payable | $3.6M | $3.4M | $6.1M | $4.8M | $5.6M | |
| Accrued Expenses | $3.3M | $12.4M | $7.8M | $1.3M | $2.5M | |
| Current Portion Of Long-Term Debt | -- | -- | -- | -- | -- | |
| Current Portion Of Capital Lease Obligations | -- | -- | -- | $365K | $396K | |
| Other Current Liabilities | $2.1M | $9.7M | $2.9M | $1.4M | $2M | |
| Total Current Liabilities | $21.7M | $48M | $31M | $23.4M | $23.9M | |
| Long-Term Debt | -- | -- | -- | -- | -- | |
| Capital Leases | -- | -- | -- | -- | -- | |
| Total Liabilities | $43.6M | $55.6M | $36.5M | $28.4M | $28.3M | |
| Common Stock | $4K | $5K | $5K | $5K | $5K | |
| Other Common Equity Adj | $10K | -$222K | -$40K | -- | -- | |
| Common Equity | $45M | $161.9M | $117.6M | $72.6M | $57.8M | |
| Total Preferred Equity | -- | -- | -- | -- | -- | |
| Minority Interest, Total | -- | -- | -- | -- | -- | |
| Total Equity | $45M | $161.9M | $117.6M | $72.6M | $57.8M | |
| Total Liabilities and Equity | $88.6M | $217.6M | $154.1M | $101M | $86.2M | |
| Cash and Short Terms | $33.4M | $81M | $55M | $37.7M | $32.1M | |
| Total Debt | -- | -- | -- | -- | -- | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Cash and Equivalents | $11.8M | $22.7M | $48.7M | $38.8M | $9.2M | |
| Short Term Investments | $84.7M | $60M | -- | -- | $24.3M | |
| Accounts Receivable, Net | $7M | $13.4M | $9.7M | $4.9M | $7.7M | |
| Inventory | -- | -- | -- | -- | -- | |
| Prepaid Expenses | -- | -- | -- | -- | -- | |
| Other Current Assets | $5.2M | $4.2M | $2.2M | $1.8M | $1.2M | |
| Total Current Assets | $114.8M | $102.5M | $61.1M | $45.6M | $42.5M | |
| Property Plant And Equipment | $1.3M | $5.2M | $4.6M | $3.9M | $3.5M | |
| Long-Term Investments | $75.4M | $10.6M | $10.5M | $4.6M | $9.2M | |
| Goodwill | -- | $2.8M | -- | -- | -- | |
| Other Intangibles | $39.2M | $79.4M | $66.4M | $40.2M | $29.8M | |
| Other Long-Term Assets | $267K | $686K | $493K | $311K | $244K | |
| Total Assets | $230.9M | $201.2M | $143.1M | $94.6M | $85.3M | |
| Accounts Payable | $6.1M | $8.4M | $7.5M | $3.3M | $4.8M | |
| Accrued Expenses | $2.3M | $9.2M | $3.4M | $4.8M | $3.4M | |
| Current Portion Of Long-Term Debt | -- | -- | -- | -- | -- | |
| Current Portion Of Capital Lease Obligations | -- | -- | -- | -- | $404K | |
| Other Current Liabilities | $3.5M | $4M | $1.7M | $74K | $2.8M | |
| Total Current Liabilities | $28.7M | $46.3M | $26.4M | $22.8M | $22.8M | |
| Long-Term Debt | -- | -- | -- | -- | -- | |
| Capital Leases | -- | -- | -- | -- | -- | |
| Total Liabilities | $54.7M | $53.7M | $31.9M | $27.6M | $27.1M | |
| Common Stock | $5K | $5K | $5K | $5K | $5K | |
| Other Common Equity Adj | -$444K | -$455K | -- | -- | -- | |
| Common Equity | -- | -- | -- | -- | -- | |
| Total Preferred Equity | -- | -- | -- | -- | -- | |
| Minority Interest, Total | -- | -- | -- | -- | -- | |
| Total Equity | $176.2M | $147.5M | $111.2M | $67M | $58.1M | |
| Total Liabilities and Equity | $230.9M | $201.2M | $143.1M | $94.6M | $85.3M | |
| Cash and Short Terms | $96.5M | $82.7M | $48.7M | $38.8M | $33.4M | |
| Total Debt | -- | -- | -- | -- | -- | |
| Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | -$48.6M | -$37.6M | -$50.9M | -$48.9M | -$12.9M | |
| Depreciation & Amoritzation | $10.1M | $28.5M | $40M | $23.4M | $19.5M | |
| Stock-Based Compensation | $4.3M | $7M | $6.6M | $4M | $6.6M | |
| Change in Accounts Receivable | -$5.4M | -$16.2M | $11.9M | $6.1M | -$1.3M | |
| Change in Inventories | -- | -- | -- | -- | -- | |
| Cash From Operations | -$53.5M | -$73.2M | -$39.5M | -$16.2M | $8.2M | |
| Capital Expenditures | $367K | $351K | $130K | $5K | -- | |
| Cash Acquisitions | -- | -$15M | -$2.4M | -$992K | -- | |
| Cash From Investing | $25.5M | -$74.9M | $62.7M | $14M | -$31.4M | |
| Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -$4.1M | |
| Special Dividend Paid | ||||||
| Long-Term Debt Issued | $9.8M | -- | -- | -- | -- | |
| Long-Term Debt Repaid | -$9.8M | -- | -- | -- | -- | |
| Repurchase of Common Stock | -- | -- | -- | -- | -$251K | |
| Other Financing Activities | $36.4M | -$1.2M | -$218K | -$123K | -$2.7M | |
| Cash From Financing | $36.6M | $148.3M | -$218K | -$123K | -$7M | |
| Beginning Cash (CF) | $8.8M | $17.4M | $17.5M | $40.5M | $38.2M | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | $8.6M | $163K | $23M | -$2.3M | -$30.3M | |
| Ending Cash (CF) | $17.4M | $17.5M | $40.5M | $38.2M | $8M | |
| Levered Free Cash Flow | -$53.9M | -$73.6M | -$39.7M | -$16.2M | $8.2M | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | -$18.8M | -$15.9M | -$7.8M | -$5M | $319K | |
| Depreciation & Amoritzation | $2.8M | $9.2M | $6M | $5.3M | $3.6M | |
| Stock-Based Compensation | $2.3M | $1.8M | $1.3M | $689K | $863K | |
| Change in Accounts Receivable | $300K | $10.1M | $1.2M | -$116K | -$1.6M | |
| Change in Inventories | -- | -- | -- | -- | -- | |
| Cash From Operations | -$12.6M | -$12.3M | -$6.3M | $666K | $1.9M | |
| Capital Expenditures | -- | $22K | $5K | -- | $77K | |
| Cash Acquisitions | -- | -$813K | -- | -- | -- | |
| Cash From Investing | -$135.7M | $19.8M | $15M | -- | $2.1M | |
| Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -$2.3M | |
| Special Dividend Paid | -- | -- | -- | -- | -- | |
| Long-Term Debt Issued | -- | -- | -- | -- | -- | |
| Long-Term Debt Repaid | -- | -- | -- | -- | -- | |
| Repurchase of Common Stock | -- | -- | -- | -- | -- | |
| Other Financing Activities | -$413K | -$137K | -$26K | -$6K | -$358K | |
| Cash From Financing | $148.9M | -$137K | -$26K | -$6K | -$2.6M | |
| Beginning Cash (CF) | $17.4M | $17.5M | $40.5M | $38.2M | $8M | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | $636K | $7.3M | $8.7M | $660K | $1.4M | |
| Ending Cash (CF) | $18M | $24.9M | $49.2M | $38.9M | $9.3M | |
| Levered Free Cash Flow | -$12.6M | -$12.3M | -$6.3M | $666K | $1.8M | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | -$55.6M | -$34.8M | -$42.8M | -$46.2M | -$7.6M | |
| Depreciation & Amoritzation | $11.3M | $34.9M | $36.7M | $22.8M | $17.7M | |
| Stock-Based Compensation | $6.3M | $6.4M | $6.1M | $3.4M | $6.7M | |
| Change in Accounts Receivable | -$4.4M | -$6.5M | $3M | $4.8M | -$2.8M | |
| Change in Inventories | -- | -- | -- | -- | -- | |
| Cash From Operations | -$43.8M | -$72.9M | -$33.5M | -$9.2M | $9.4M | |
| Capital Expenditures | $173K | $373K | $113K | -- | $77K | |
| Cash Acquisitions | -- | -$15.8M | -$1.6M | -$992K | -- | |
| Cash From Investing | -$135.7M | $80.5M | $57.9M | -$992K | -$29.3M | |
| Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -$6.3M | |
| Special Dividend Paid | ||||||
| Long-Term Debt Issued | -- | -- | -- | -- | -- | |
| Long-Term Debt Repaid | -- | -- | -- | -- | -- | |
| Repurchase of Common Stock | -- | -- | -- | -- | -- | |
| Other Financing Activities | -- | -$885K | -$107K | -$103K | -$3M | |
| Cash From Financing | $184.5M | -$676K | -$107K | -$103K | -$9.6M | |
| Beginning Cash (CF) | -- | -- | -- | -- | -- | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | $5M | $6.9M | $24.3M | -$10.3M | -$29.6M | |
| Ending Cash (CF) | -- | -- | -- | -- | -- | |
| Levered Free Cash Flow | -$44M | -$73.3M | -$33.7M | -$9.2M | $9.3M | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | -$18.8M | -$15.9M | -$7.8M | -$5M | $319K | |
| Depreciation & Amoritzation | $2.8M | $9.2M | $6M | $5.3M | $3.6M | |
| Stock-Based Compensation | $2.3M | $1.8M | $1.3M | $689K | $863K | |
| Change in Accounts Receivable | $300K | $10.1M | $1.2M | -$116K | -$1.6M | |
| Change in Inventories | -- | -- | -- | -- | -- | |
| Cash From Operations | -$12.6M | -$12.3M | -$6.3M | $666K | $1.9M | |
| Capital Expenditures | -- | $22K | $5K | -- | $77K | |
| Cash Acquisitions | -- | -$813K | -- | -- | -- | |
| Cash From Investing | -$135.7M | $19.8M | $15M | -- | $2.1M | |
| Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -$2.3M | |
| Special Dividend Paid | -- | -- | -- | -- | -- | |
| Long-Term Debt Issued | -- | -- | -- | -- | -- | |
| Long-Term Debt Repaid | -- | -- | -- | -- | -- | |
| Repurchase of Common Stock | -- | -- | -- | -- | -- | |
| Other Financing Activities | -$413K | -$137K | -$26K | -$6K | -$358K | |
| Cash From Financing | $148.9M | -$137K | -$26K | -$6K | -$2.6M | |
| Beginning Cash (CF) | $17.4M | $17.5M | $40.5M | $38.2M | $8M | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | $636K | $7.3M | $8.7M | $660K | $1.4M | |
| Ending Cash (CF) | $18M | $24.9M | $49.2M | $38.9M | $9.3M | |
| Levered Free Cash Flow | -$12.6M | -$12.3M | -$6.3M | $666K | $1.8M | |
Get CURI Stock Alert
Signup to receive the latest stock alerts
Financial Ratios
CURI
Sector
P/E ratio
--
17.05x
PEG ratio
-1.52x
0.00x
P/B ratio
6.74x
1.44x
Price / LTM sales
6.97x
0.95x
Growth Metrics
CURI
Sector
Revenue growth
25.74%
-0.19%
Earnings growth
--
-1.02%
Revenue (5-year growth)
23.19%
1.59%
Earnings forecast
-$0.02
$0.04
Profitability
CURI
Sector
Profitability FY 2024
$25.8M
$269.7M
Return on invested capital
-12.24%
0.22%
Return on assets
-8.54%
-0.05%
Return on equity
-12.24%
1.9%
Earnings Date
Last Earnings Date
May
6
Next Earnings Date
Aug
13
Estimated Next Earnings Date
Aug
5
Balance Sheet
CURI
Sector
Total cash
$33.4M
$104.5M
Short term investments
$24.2M
$28.1M
Total assets
$86.2M
$851.1M
Long term debt
--
$42.3M
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Where Will Salesforce Stock Be in 5 Years?
Salesforce (NYSE: CRM) just turned in a quarter that, on…
2 Ultra Safe Dividend Stocks to Buy Now
Historically, blue-chip dividend stocks have been good choices for periods…
Stock Ideas
Buy
67
Is MSFT Stock a Buy?
Market Cap: $3.4T
P/E Ratio: 39x
Buy
65
Is NVDA Stock a Buy?
Market Cap: $3.3T
P/E Ratio: 46x
Sell
40
Is AAPL Stock a Buy?
Market Cap: $3T
P/E Ratio: 33x
Alerts
Sell
31
REGN alert for May 31
Regeneron Pharmaceuticals [REGN] is down 19.04% over the past day.
Buy
55
RGC alert for May 31
Regencell Bioscience Holdings [RGC] is up 16.13% over the past day.
Sell
42
AMBA alert for May 31
Ambarella [AMBA] is down 15.13% over the past day.
THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS
Show me the best stock
